254 related articles for article (PubMed ID: 17938253)
21. PKCtheta and PKA are antagonistic partners in the NF-AT transactivation pathway of primary mouse CD3+ T lymphocytes.
Hermann-Kleiter N; Thuille N; Pfeifhofer C; Gruber T; Schäfer M; Zitt C; Hatzelmann A; Schudt C; Leitges M; Baier G
Blood; 2006 Jun; 107(12):4841-8. PubMed ID: 16514061
[TBL] [Abstract][Full Text] [Related]
22. Multiple signals required for cyclic AMP-responsive element binding protein (CREB) binding protein interaction induced by CD3/CD28 costimulation.
Yu CT; Shih HM; Lai MZ
J Immunol; 2001 Jan; 166(1):284-92. PubMed ID: 11123304
[TBL] [Abstract][Full Text] [Related]
23. Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice.
Dufresne SD; Bjørbaek C; El-Haschimi K; Zhao Y; Aschenbach WG; Moller DE; Goodyear LJ
Mol Cell Biol; 2001 Jan; 21(1):81-7. PubMed ID: 11113183
[TBL] [Abstract][Full Text] [Related]
24. TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity.
Govers C; Sebestyén Z; Roszik J; van Brakel M; Berrevoets C; Szöőr Á; Panoutsopoulou K; Broertjes M; Van T; Vereb G; Szöllősi J; Debets R
J Immunol; 2014 Nov; 193(10):5315-26. PubMed ID: 25320284
[TBL] [Abstract][Full Text] [Related]
25. TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity.
Pouw N; Treffers-Westerlaken E; Mondino A; Lamers C; Debets R
Mol Immunol; 2010 Apr; 47(7-8):1411-20. PubMed ID: 20303179
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.
Kang S; Dong S; Guo A; Ruan H; Lonial S; Khoury HJ; Gu TL; Chen J
J Biol Chem; 2008 Feb; 283(8):4652-7. PubMed ID: 18156174
[TBL] [Abstract][Full Text] [Related]
27. The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways.
de Totero D; Meazza R; Capaia M; Fabbi M; Azzarone B; Balleari E; Gobbi M; Cutrona G; Ferrarini M; Ferrini S
Blood; 2008 Jan; 111(2):517-24. PubMed ID: 17938255
[TBL] [Abstract][Full Text] [Related]
28. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
[TBL] [Abstract][Full Text] [Related]
29. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
[TBL] [Abstract][Full Text] [Related]
30. PI3-kinase and MAP-kinase signaling cascades in AILIM/ICOS- and CD28-costimulated T-cells have distinct functions between cell proliferation and IL-10 production.
Okamoto N; Tezuka K; Kato M; Abe R; Tsuji T
Biochem Biophys Res Commun; 2003 Oct; 310(3):691-702. PubMed ID: 14550257
[TBL] [Abstract][Full Text] [Related]
31. A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects.
Kagoya Y; Tanaka S; Guo T; Anczurowski M; Wang CH; Saso K; Butler MO; Minden MD; Hirano N
Nat Med; 2018 Mar; 24(3):352-359. PubMed ID: 29400710
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool.
Hehner SP; Breitkreutz R; Shubinsky G; Unsoeld H; Schulze-Osthoff K; Schmitz ML; Dröge W
J Immunol; 2000 Oct; 165(8):4319-28. PubMed ID: 11035067
[TBL] [Abstract][Full Text] [Related]
33. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin.
Colombetti S; Basso V; Mueller DL; Mondino A
J Immunol; 2006 Mar; 176(5):2730-8. PubMed ID: 16493028
[TBL] [Abstract][Full Text] [Related]
34. Altered ERK/MAPK signaling in the hippocampus of the mrsk2_KO mouse model of Coffin-Lowry syndrome.
Schneider A; Mehmood T; Pannetier S; Hanauer A
J Neurochem; 2011 Nov; 119(3):447-59. PubMed ID: 21838783
[TBL] [Abstract][Full Text] [Related]
35. Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes.
Nishina H; Bachmann M; Oliveira-dos-Santos AJ; Kozieradzki I; Fischer KD; Odermatt B; Wakeham A; Shahinian A; Takimoto H; Bernstein A; Mak TW; Woodgett JR; Ohashi PS; Penninger JM
J Exp Med; 1997 Sep; 186(6):941-53. PubMed ID: 9294148
[TBL] [Abstract][Full Text] [Related]
36. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway.
Yu TK; Caudell EG; Smid C; Grimm EA
J Immunol; 2000 Jun; 164(12):6244-51. PubMed ID: 10843677
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of RXR alpha during activation of cycling human T lymphocytes: modulation of RXRE transactivation function by mitogen-activated protein kinase pathways.
Ishaq M; Fan M; Natarajan V
J Immunol; 2000 Oct; 165(8):4217-25. PubMed ID: 11035054
[TBL] [Abstract][Full Text] [Related]
38. p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling.
Sheffler DJ; Kroeze WK; Garcia BG; Deutch AY; Hufeisen SJ; Leahy P; Brüning JC; Roth BL
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4717-22. PubMed ID: 16537434
[TBL] [Abstract][Full Text] [Related]
39. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154.
Säemann MD; Zeyda M; Diakos C; Szekeres A; Böhmig GA; Kelemen P; Parolini O; Stockinger H; Prieschl EE; Stulnig TM; Baumruker T; Zlabinger GJ
Transplantation; 2003 Jun; 75(11):1864-72. PubMed ID: 12811247
[TBL] [Abstract][Full Text] [Related]
40. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
